Lumexa Imaging Holdings, Inc. (LMRI)
NASDAQ:LMRI
Want to see LMRI full AI Analyst Report?
Earnings Data
Report Date
Apr 01, 2027Before Open (Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-0.38Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a constructive growth story: revenue and advanced modality volumes expanded (notably PET +23%), adjusted EBITDA held steady at $51.2 million, profitability returned to positive net income, and management reiterated full-year guidance while outlining disciplined growth via de novos, JVs and technology adoption. Near-term headwinds included a roughly $4 million weather and seasonality EBITDA drag, slower routine scans and mammography, higher public company and stock-based compensation costs, and a Q1 free cash flow shortfall. On balance, the operational momentum in high-margin advanced services, improved cash flow trajectory, successful JV and de novo activity, and affirmed guidance outweigh the transitory and timing-related challenges discussed on the call.Company Guidance
Revenue Growth and Scale
Consolidated revenues of $253 million, up 3% year-over-year, and system-wide revenue growth of 4% for the quarter, driven approximately two-thirds by volume and one-third by rate.
Strong Advanced Modality Performance
Advanced modalities grew 7% year-over-year system-wide and consolidated, with PET up 23.1% year-over-year and MRI up 8.2% year-over-year; advanced scans comprised 37.4% of total volume, a 160 basis point improvement versus Q1 2025.
Profitability Improvement and EPS
Pretax income improved to $3 million from a pretax loss of $4 million in Q1 2025; net income was $2 million versus a net loss of $8 million prior year. GAAP EPS was $0.02 and adjusted EPS was $0.18.
Adjusted EBITDA Resilience
Adjusted EBITDA was $51.2 million, essentially flat versus $51.1 million a year ago, with an adjusted EBITDA margin of 20.3% and management reiterating full-year adjusted EBITDA guidance of $234 million to $242 million.
Improved Cash Flow Profile
Cash flows from operating activities were $3 million, a $17 million improvement year-over-year, and free cash flow was negative $2 million, a $13 million improvement versus prior year; interest expense run rate fell by about $14 million versus Q1 2025 after IPO debt paydown.
Disciplined Capital Deployment and Guidance
Q1 CapEx of $5 million with expected quarterly CapEx of $5 million to $7 million (mid-to-upper $20s full year). Full-year revenue guidance of $1.045 billion to $1.097 billion and adjusted EPS guidance of $0.71 to $0.77 reaffirmed.
Growth via De Novos, JVs and M&A
Opened 4 new centers (2 tuck-in acquisitions and 2 de novos) in Q1, completed first IDTF acquisition in Pennsylvania as part of the UPMC JV, and have 15 centers opened since late 2024 that are ramping; company targeting 8 to 10 de novos annually.
Technology and Operational Enhancements
FastScan deployment driving MRI productivity; beginning the year at 51% MRI fleet adoption and targeting roughly 66-67% by year-end. Virtual cockpit remote MRI scanning and AI-enabled offerings (breast arterial calcification) expanding strategic service lines and efficiency.
LMRI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
LMRI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 12, 2026 | $10.50 | $8.05 | -23.33% |
Mar 26, 2026 | $11.06 | $7.76 | -29.84% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Lumexa Imaging Holdings, Inc. (LMRI) report earnings?
Lumexa Imaging Holdings, Inc. (LMRI) is schdueled to report earning on Apr 01, 2027, Before Open (Confirmed).
What is Lumexa Imaging Holdings, Inc. (LMRI) earnings time?
Lumexa Imaging Holdings, Inc. (LMRI) earnings time is at Apr 01, 2027, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is LMRI EPS forecast?
Currently, no data Available